William Bonnez
Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Papillomaviridae | 25 | 1987 | 37 |
Why?
| Condylomata Acuminata | 15 | 1987 | 16 |
Why?
| Papillomavirus Infections | 7 | 1994 | 39 |
Why?
| Tumor Virus Infections | 7 | 1991 | 31 |
Why?
| Skin Transplantation | 4 | 1993 | 39 |
Why?
| Antibodies, Viral | 9 | 1989 | 104 |
Why?
| Papillomavirus Vaccines | 3 | 2001 | 19 |
Why?
| Viral Vaccines | 5 | 1991 | 35 |
Why?
| Mice, SCID | 4 | 1993 | 61 |
Why?
| Warts | 3 | 1991 | 13 |
Why?
| Sexually Transmitted Diseases | 1 | 2005 | 18 |
Why?
| Humans | 44 | 1980 | 1856 |
Why?
| Meat Products | 1 | 2002 | 2 |
Why?
| Skin Diseases | 2 | 1991 | 69 |
Why?
| Skin | 4 | 1993 | 177 |
Why?
| Virus Replication | 5 | 1980 | 90 |
Why?
| Mouth Diseases | 1 | 2002 | 19 |
Why?
| Cryosurgery | 3 | 1994 | 12 |
Why?
| Severe Combined Immunodeficiency | 2 | 1994 | 9 |
Why?
| Antiviral Agents | 2 | 1996 | 91 |
Why?
| Occupational Exposure | 1 | 2002 | 53 |
Why?
| Interferon-beta | 2 | 1995 | 26 |
Why?
| HIV Infections | 3 | 1992 | 136 |
Why?
| Mice, Nude | 3 | 1992 | 72 |
Why?
| Virion | 5 | 1991 | 24 |
Why?
| Interferons | 2 | 1995 | 39 |
Why?
| Transplantation, Heterologous | 4 | 1993 | 57 |
Why?
| Interferon-alpha | 3 | 1990 | 43 |
Why?
| Female | 22 | 1980 | 1643 |
Why?
| Biopsy | 2 | 1991 | 207 |
Why?
| Penile Neoplasms | 2 | 1993 | 12 |
Why?
| Cefotaxime | 1 | 1997 | 4 |
Why?
| Meningitis, Pneumococcal | 1 | 1997 | 8 |
Why?
| Cryotherapy | 1 | 1997 | 12 |
Why?
| Antigens, Viral | 4 | 1989 | 53 |
Why?
| Aneurysm, Infected | 1 | 1996 | 10 |
Why?
| Neisseria | 1 | 1996 | 6 |
Why?
| Cephalosporins | 1 | 1997 | 22 |
Why?
| Viral Proteins | 2 | 1993 | 71 |
Why?
| Endocarditis, Bacterial | 1 | 1996 | 26 |
Why?
| Male | 21 | 1988 | 1553 |
Why?
| Mice | 9 | 1992 | 623 |
Why?
| Recurrence | 6 | 1988 | 261 |
Why?
| Podophyllotoxin | 1 | 1994 | 7 |
Why?
| Anus Diseases | 1 | 1994 | 7 |
Why?
| Genital Diseases, Female | 1 | 1994 | 22 |
Why?
| Genital Diseases, Male | 1 | 1994 | 13 |
Why?
| Combined Modality Therapy | 4 | 1994 | 219 |
Why?
| Animals | 15 | 1989 | 1031 |
Why?
| Temperature | 1 | 1994 | 137 |
Why?
| Adult | 19 | 1985 | 1317 |
Why?
| Capsid | 4 | 1990 | 14 |
Why?
| Respiratory Tract Diseases | 1 | 1992 | 34 |
Why?
| Bovine papillomavirus 1 | 2 | 1989 | 6 |
Why?
| DNA, Viral | 6 | 1989 | 98 |
Why?
| Vaccines, DNA | 2 | 2001 | 16 |
Why?
| Double-Blind Method | 6 | 1988 | 274 |
Why?
| RNA, Viral | 2 | 1990 | 91 |
Why?
| Zidovudine | 3 | 1992 | 23 |
Why?
| Oncogene Proteins, Viral | 3 | 1992 | 29 |
Why?
| Monocytes | 1 | 1991 | 124 |
Why?
| Macrophages | 1 | 1991 | 148 |
Why?
| Rabbits | 6 | 1989 | 252 |
Why?
| RNA, Messenger | 2 | 1989 | 394 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 1991 | 224 |
Why?
| Uterine Cervical Neoplasms | 2 | 1998 | 55 |
Why?
| Research Personnel | 1 | 2006 | 17 |
Why?
| Keratinocytes | 2 | 1998 | 36 |
Why?
| Remission, Spontaneous | 1 | 2005 | 32 |
Why?
| Genitalia | 1 | 2005 | 9 |
Why?
| Actinomycosis | 1 | 1985 | 5 |
Why?
| Pelvic Inflammatory Disease | 1 | 1985 | 9 |
Why?
| Intrauterine Devices | 1 | 1985 | 7 |
Why?
| Polymerase Chain Reaction | 2 | 1992 | 279 |
Why?
| Interferon Type I | 3 | 1988 | 22 |
Why?
| Recombinant Proteins | 6 | 1989 | 290 |
Why?
| Treatment Outcome | 2 | 1996 | 661 |
Why?
| T-Lymphocyte Subsets | 2 | 1998 | 70 |
Why?
| Neutralization Tests | 2 | 1992 | 37 |
Why?
| Antigens, CD | 2 | 1998 | 128 |
Why?
| Uterine Cervical Diseases | 1 | 2002 | 10 |
Why?
| Plant Proteins | 1 | 2002 | 9 |
Why?
| Thymidine Kinase | 1 | 2002 | 15 |
Why?
| Prognosis | 1 | 2005 | 388 |
Why?
| Oligonucleotides, Antisense | 1 | 2002 | 46 |
Why?
| Adolescent | 5 | 1980 | 891 |
Why?
| Tuberculosis, Pulmonary | 1 | 2002 | 20 |
Why?
| Plant Extracts | 1 | 2002 | 22 |
Why?
| Mycobacterium tuberculosis | 1 | 2002 | 17 |
Why?
| Prevalence | 2 | 1993 | 281 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2002 | 27 |
Why?
| Indoles | 1 | 2002 | 69 |
Why?
| Genetic Variation | 1 | 2002 | 91 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 1993 | 113 |
Why?
| Middle Aged | 7 | 1992 | 1161 |
Why?
| Child | 2 | 1992 | 749 |
Why?
| Photochemotherapy | 1 | 2002 | 18 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 1998 | 91 |
Why?
| Cells, Cultured | 7 | 1980 | 447 |
Why?
| Carcinoma, Squamous Cell | 1 | 2002 | 111 |
Why?
| Infant | 1 | 2005 | 464 |
Why?
| HIV-1 | 2 | 1993 | 93 |
Why?
| Follow-Up Studies | 3 | 1990 | 553 |
Why?
| Injections, Subcutaneous | 2 | 1990 | 63 |
Why?
| Drug Resistance, Microbial | 2 | 1993 | 53 |
Why?
| Drug Therapy, Combination | 2 | 1997 | 189 |
Why?
| Microbial Sensitivity Tests | 2 | 1993 | 71 |
Why?
| Cytomegalovirus Retinitis | 1 | 1998 | 2 |
Why?
| Indinavir | 1 | 1998 | 6 |
Why?
| Lamivudine | 1 | 1998 | 18 |
Why?
| Chickenpox | 1 | 1998 | 20 |
Why?
| Capsid Proteins | 2 | 1993 | 19 |
Why?
| HIV Protease Inhibitors | 1 | 1998 | 25 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 1998 | 41 |
Why?
| Interferon-gamma | 2 | 1995 | 133 |
Why?
| Drug Resistance, Multiple | 1 | 1997 | 19 |
Why?
| Base Sequence | 4 | 1993 | 371 |
Why?
| Blotting, Western | 4 | 1989 | 275 |
Why?
| Anti-HIV Agents | 1 | 1998 | 44 |
Why?
| Molecular Sequence Data | 4 | 1993 | 404 |
Why?
| Membrane Glycoproteins | 2 | 1994 | 154 |
Why?
| Streptococcus pneumoniae | 1 | 1997 | 38 |
Why?
| Sexual Partners | 1 | 1995 | 23 |
Why?
| Subrenal Capsule Assay | 1 | 1994 | 3 |
Why?
| DNA Probes, HPV | 1 | 1994 | 3 |
Why?
| Blotting, Southern | 2 | 1991 | 69 |
Why?
| Baculoviridae | 2 | 1990 | 23 |
Why?
| Dermatitis, Contact | 1 | 1994 | 9 |
Why?
| Pruritus | 1 | 1994 | 14 |
Why?
| Lymphocyte Activation | 3 | 1998 | 137 |
Why?
| Random Allocation | 2 | 1988 | 160 |
Why?
| Safety | 1 | 1994 | 80 |
Why?
| Remission Induction | 1 | 1994 | 64 |
Why?
| Placebos | 1 | 1994 | 110 |
Why?
| Dose-Response Relationship, Drug | 1 | 1997 | 431 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 43 |
Why?
| Didanosine | 1 | 1993 | 8 |
Why?
| Hemophilia A | 1 | 1992 | 23 |
Why?
| Virus Cultivation | 1 | 1992 | 24 |
Why?
| DNA Replication | 1 | 1993 | 75 |
Why?
| Electrophoresis, Agar Gel | 1 | 1992 | 27 |
Why?
| Immune Sera | 1 | 1992 | 56 |
Why?
| Gene Products, env | 1 | 1991 | 5 |
Why?
| Protein Precursors | 1 | 1991 | 48 |
Why?
| Open Reading Frames | 1 | 1990 | 56 |
Why?
| Pain | 1 | 1994 | 191 |
Why?
| Leukocytes, Mononuclear | 1 | 1991 | 67 |
Why?
| Immunophenotyping | 2 | 1998 | 66 |
Why?
| Kidney | 1 | 1993 | 223 |
Why?
| Retrospective Studies | 1 | 1996 | 653 |
Why?
| Reference Values | 1 | 1991 | 278 |
Why?
| Interleukin-1 | 1 | 1991 | 109 |
Why?
| Cattle | 1 | 1991 | 176 |
Why?
| Immunologic Memory | 2 | 1998 | 51 |
Why?
| Risk Factors | 1 | 1996 | 555 |
Why?
| Codon | 1 | 1989 | 41 |
Why?
| Antigens, Bacterial | 1 | 1989 | 44 |
Why?
| Infant, Newborn | 1 | 1993 | 389 |
Why?
| DNA-Binding Proteins | 1 | 1993 | 204 |
Why?
| Immunohistochemistry | 1 | 1992 | 355 |
Why?
| Flow Cytometry | 2 | 1998 | 216 |
Why?
| Herpesviridae | 1 | 1987 | 13 |
Why?
| Recombinant Fusion Proteins | 1 | 1989 | 189 |
Why?
| Fluorouracil | 1 | 1987 | 49 |
Why?
| Escherichia coli | 1 | 1989 | 143 |
Why?
| Child, Preschool | 1 | 1992 | 554 |
Why?
| Cloning, Molecular | 3 | 1989 | 183 |
Why?
| Actinomyces | 1 | 1985 | 11 |
Why?
| Moths | 2 | 1990 | 16 |
Why?
| Gene Expression Regulation | 1 | 1989 | 277 |
Why?
| Aged | 1 | 1995 | 988 |
Why?
| NAD+ Nucleosidase | 1 | 2002 | 6 |
Why?
| ADP-ribosyl Cyclase | 1 | 2002 | 6 |
Why?
| Antigens, CD38 | 1 | 2002 | 7 |
Why?
| Antigens, CD27 | 1 | 2002 | 7 |
Why?
| Antigens, CD45 | 1 | 2002 | 30 |
Why?
| HLA-DR Antigens | 1 | 2002 | 37 |
Why?
| Lymphocyte Count | 1 | 2002 | 38 |
Why?
| Antigens, Differentiation | 1 | 2002 | 53 |
Why?
| Interleukin-5 | 1 | 2001 | 20 |
Why?
| SSPE Virus | 1 | 1980 | 1 |
Why?
| Subacute Sclerosing Panencephalitis | 1 | 1980 | 2 |
Why?
| Measles virus | 1 | 1980 | 10 |
Why?
| Measles | 1 | 1980 | 13 |
Why?
| Species Specificity | 1 | 2001 | 186 |
Why?
| Astrocytoma | 1 | 1980 | 26 |
Why?
| Cross Reactions | 2 | 1989 | 63 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 50 |
Why?
| Viral Load | 1 | 1998 | 53 |
Why?
| Statistics, Nonparametric | 1 | 1998 | 141 |
Why?
| T-Lymphocytes | 1 | 2001 | 182 |
Why?
| Leukocyte L1 Antigen Complex | 1 | 1994 | 6 |
Why?
| Time Factors | 2 | 1991 | 896 |
Why?
| Antibody Specificity | 1 | 1994 | 71 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1993 | 88 |
Why?
| Lepidoptera | 1 | 1993 | 4 |
Why?
| Genes, pol | 1 | 1993 | 5 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 48 |
Why?
| AIDS-Related Complex | 1 | 1993 | 7 |
Why?
| HIV Core Protein p24 | 1 | 1993 | 17 |
Why?
| Enhancer Elements, Genetic | 1 | 1993 | 43 |
Why?
| Virus Integration | 1 | 1993 | 17 |
Why?
| Chromosome Mapping | 1 | 1993 | 107 |
Why?
| Metabolic Clearance Rate | 1 | 1992 | 31 |
Why?
| Leukocyte Count | 1 | 1993 | 94 |
Why?
| Macromolecular Substances | 1 | 1993 | 92 |
Why?
| Half-Life | 1 | 1992 | 69 |
Why?
| Microscopy, Electron | 1 | 1993 | 178 |
Why?
| Injections, Intravenous | 1 | 1992 | 105 |
Why?
| Immunoblotting | 1 | 1993 | 119 |
Why?
| 3T3 Cells | 1 | 1992 | 54 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 86 |
Why?
| Blood Coagulation | 1 | 1992 | 57 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1992 | 121 |
Why?
| Epithelium | 1 | 1992 | 101 |
Why?
| Administration, Oral | 1 | 1992 | 170 |
Why?
| HIV Envelope Protein gp160 | 1 | 1991 | 5 |
Why?
| Drug Evaluation | 1 | 1991 | 54 |
Why?
| Bisexuality | 1 | 1990 | 9 |
Why?
| Homosexuality | 1 | 1990 | 17 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 85 |
Why?
| Genetic Vectors | 1 | 1993 | 139 |
Why?
| Vaccines, Synthetic | 1 | 1991 | 30 |
Why?
| Immunity, Cellular | 1 | 1991 | 85 |
Why?
| Epithelial Cells | 1 | 1992 | 135 |
Why?
| Cell Line | 1 | 1994 | 375 |
Why?
| Regression Analysis | 1 | 1990 | 256 |
Why?
| beta-Galactosidase | 1 | 1989 | 63 |
Why?
| Fibroblasts | 1 | 1992 | 179 |
Why?
| Anus Neoplasms | 1 | 1988 | 11 |
Why?
| Genital Neoplasms, Female | 1 | 1988 | 27 |
Why?
| Sex Factors | 1 | 1990 | 284 |
Why?
| Genital Neoplasms, Male | 1 | 1988 | 16 |
Why?
| Injections | 1 | 1988 | 53 |
Why?
| Epitopes | 1 | 1989 | 86 |
Why?
| Cell Division | 1 | 1991 | 273 |
Why?
| Transcription, Genetic | 1 | 1992 | 253 |
Why?
| Cell Differentiation | 1 | 1992 | 262 |
Why?
| Neoplasm Recurrence, Local | 1 | 1988 | 118 |
Why?
| Clinical Trials as Topic | 1 | 1988 | 251 |
Why?
| Inclusion Bodies, Viral | 1 | 1980 | 3 |
Why?
|
|
Bonnez's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
